Published on
November 3, 2020
- 15:00 GMT
KDX SELECTS ACUPATH AS LAB FOR URO17™ FDA CLINICAL TRIAL
INNOVATIVE BLADDER CANCER BIOMARKER DEMONSTRATES COMPELLING CLINICAL UTILITY PLAINVIEW, NY, UNITED STATES, November 3, 2020 /EINPresswire.com/ -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
